CL2007002007A1 - Compuestos derivados de benzofuro y benzotienopirimidinas, moduladores del receptor de histamina h4; procedimiento de preparacion; y su uso para tratar trastornos inflamatorios, alergicos, dermatologicos, enfermedades autoinmune, linfaticas y de inmu - Google Patents

Compuestos derivados de benzofuro y benzotienopirimidinas, moduladores del receptor de histamina h4; procedimiento de preparacion; y su uso para tratar trastornos inflamatorios, alergicos, dermatologicos, enfermedades autoinmune, linfaticas y de inmu

Info

Publication number: CL2007002007A1
Authority: CL; Chile
Prior art keywords: benzotienopirimidinas; benzofuro; immu; dermatological; lymphatic
Prior art date: 2006-07-11

Application number

CL200702007A

Other languages

English (en)

Inventor

Frank Curtis Michael P Chavez

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-11

Filing date

2007-07-10

Publication date

2008-08-22

2007-07-10 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2008-08-22 Publication of CL2007002007A1 publication Critical patent/CL2007002007A1/es

Links

NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 title 2
230000000172 allergic effect Effects 0.000 title 1
208000010668 atopic eczema Diseases 0.000 title 1
230000001363 autoimmune Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
229960001340 histamine Drugs 0.000 title 1
230000002757 inflammatory effect Effects 0.000 title 1
230000001926 lymphatic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Reproductive Health (AREA)
Ophthalmology & Optometry (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Agronomy & Crop Science (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Pregnancy & Childbirth (AREA)
Transplantation (AREA)
Otolaryngology (AREA)

CL200702007A 2006-07-11 2007-07-10 Compuestos derivados de benzofuro y benzotienopirimidinas, moduladores del receptor de histamina h4; procedimiento de preparacion; y su uso para tratar trastornos inflamatorios, alergicos, dermatologicos, enfermedades autoinmune, linfaticas y de inmu CL2007002007A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US83019206P	2006-07-11	2006-07-11

Publications (1)

Publication Number	Publication Date
CL2007002007A1 true CL2007002007A1 (es)	2008-08-22

Family

ID=38923848

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200702007A CL2007002007A1 (es)	2006-07-11	2007-07-10	Compuestos derivados de benzofuro y benzotienopirimidinas, moduladores del receptor de histamina h4; procedimiento de preparacion; y su uso para tratar trastornos inflamatorios, alergicos, dermatologicos, enfermedades autoinmune, linfaticas y de inmu

Country Status (24)

Country	Link
US (2)	US7576092B2 (es)
EP (1)	EP2040549B1 (es)
JP (1)	JP5352458B2 (es)
KR (1)	KR20090028819A (es)
CN (1)	CN101511190A (es)
AR (1)	AR061891A1 (es)
AU (1)	AU2007272956B2 (es)
BR (1)	BRPI0715452A2 (es)
CA (1)	CA2657908A1 (es)
CL (1)	CL2007002007A1 (es)
CO (1)	CO6150182A2 (es)
CR (1)	CR10609A (es)
EA (1)	EA015344B1 (es)
EC (1)	ECSP099061A (es)
ES (1)	ES2441958T3 (es)
IL (1)	IL196448A0 (es)
MX (1)	MX2009000457A (es)
MY (1)	MY145349A (es)
NO (1)	NO20090268L (es)
PE (1)	PE20080520A1 (es)
TW (1)	TW200821315A (es)
UY (1)	UY30479A1 (es)
WO (1)	WO2008008359A2 (es)
ZA (1)	ZA200900959B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007117399A2 (en)	2006-03-31	2007-10-18	Janssen Pharmaceutica N.V.	Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
TW200904437A (en)	2007-02-14	2009-02-01	Janssen Pharmaceutica Nv	2-aminopyrimidine modulators of the histamine H4 receptor
WO2009081222A1 (en) *	2007-12-21	2009-07-02	Glenmark Pharmaceuticals, S.A.	Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands
EA019143B1 (ru) *	2008-06-12	2014-01-30	Янссен Фармацевтика Нв	Использование антагонистов н4-гистаминовых рецепторов для лечения послеоперационных спаек
US9371311B2 (en)	2008-06-30	2016-06-21	Janssen Pharmaceutica Nv	Benzoimidazol-2-yl pyrimidine derivatives
WO2010064705A1 (ja) *	2008-12-05	2010-06-10	大日本住友製薬株式会社	Ｈ４受容体アンタゴニスト作用を有する新規７位置換ジヒドロピラノピリミジン誘導体
EP2379523A1 (en)	2008-12-22	2011-10-26	Incyte Corporation	4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
EP2201982A1 (en)	2008-12-24	2010-06-30	INSERM (Institut National de la Santé et de la Recherche Médicale)	Histamine H4 receptor antagonists for the treatment of vestibular disorders
IT1393337B1 (it)	2009-03-06	2012-04-20	Italiana Sint Spa	Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina
US8481732B2 (en)	2009-03-20	2013-07-09	Incyte Corporation	Substituted heterocyclic compounds
EP2671883A1 (en) *	2012-06-05	2013-12-11	Bioprojet	New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands
PL2858647T3 (pl)	2012-06-08	2018-10-31	Sensorion	Inhibitory receptora h4 do leczenia szumów usznych
CN102875558A (zh) *	2012-11-05	2013-01-16	贵州大学	2-氯-4-取代-8-硝基苯并呋喃[3,2-d]嘧啶类化合物及其制备方法和用途
RS59909B1 (sr)	2013-03-06	2020-03-31	Janssen Pharmaceutica Nv	Benzoimidazol-2-il pirimidinski modulatori histaminskog h4 receptora
CN108602780A (zh) *	2016-01-29	2018-09-28	明治制果药业株式会社	新的化合物及其药理学上可接受的盐
CN113302194A (zh) *	2019-01-04	2021-08-24	贝尔布鲁克实验室有限责任公司	作为治疗剂的cGAS活性的抑制剂
US10778972B1 (en)	2019-02-27	2020-09-15	Google Llc	Adaptive filter intra prediction modes in image/video compression
CA3167339A1 (en)	2020-01-13	2021-07-22	Verge Analytics, Inc.	Substituted pyrazolo-pyrimidines and uses thereof
FR3109524B1 (fr) *	2020-04-22	2022-04-08	H4 Orphan Pharma	Utilisation d’un ligand multifonctionnel pour traiter l’œil sec et les dysfonctionnements des glandes de Meibomius et des glandes lacrymales.
US20240174684A1 (en) *	2021-02-11	2024-05-30	Bellbrook Labs, Llc	INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTS
CN116589472B (zh) *	2023-05-22	2024-09-13	郑州大学	一种苯并呋喃[3,2-d]并嘧啶-2-胺类化合物及其制备方法和应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3755583A (en) *	1970-06-05	1973-08-28		Chas0!nhx
US3706747A (en) *	1970-06-05	1972-12-19	Pfizer	Benzothieno(3,2-d)- and benzofuro(3,2-d)pyrimidines
US3755586A (en) *	1971-03-25	1973-08-28	Warner Lambert Co	Anti tussive compositions containing piperidine derivatives
US4703053A (en) *	1985-10-28	1987-10-27	Warner-Lambert Company	Benzothiophenes and benzofurans and antiallergic use thereof
JPH06220059A (ja) *	1993-01-28	1994-08-09	Tanabe Seiyaku Co Ltd	縮合ピリミジン誘導体及びその製法
WO1995007893A1 (en) *	1993-09-15	1995-03-23	Merck Sharp & Dohme Limited	Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
DE19647927A1 (de) *	1996-11-20	1998-05-28	Bayer Ag	Verfahren zur Herstellung einer stabilen Troponin I Präparation und dessen Verwendung als Kalibrator in Immunoassays
ES2361146T3 (es) *	1998-03-27	2011-06-14	Janssen Pharmaceutica Nv	Derivados de la piramidina inhibitatoria de vih.
EP1167367A4 (en) *	1999-03-30	2002-04-24	Nippon Soda Co	THIENOPYRIMIDINE COMPOUNDS AND SALTS THEREOF, AND PROCESS FOR THE PREPARATION THEREOF
US20040058940A1 (en) *	2000-12-19	2004-03-25	Hans-Michael Eggenweiler	Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
US6875781B2 (en) *	2003-04-04	2005-04-05	Cell Therapeutics, Inc.	Pyridines and uses thereof
AU2003275430A1 (en)	2003-10-03	2005-05-19	Ortho-Mcneil Pharmaceutical, Inc.	Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist
US7291733B2 (en) *	2003-10-10	2007-11-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted tricyclic heterocycles and their uses
US20050187389A1 (en) *	2004-01-13	2005-08-25	Ambit Biosciences Corporation	Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
MXPA06011021A (es) *	2004-03-25	2007-04-13	Johnson & Johnson	Compuestos de imidazol.
JP2008519794A (ja)	2004-11-11	2008-06-12	アージェンタ・ディスカバリー・リミテッド	ピリミジン化合物
US20060111416A1 (en) *	2004-11-24	2006-05-25	Lane Charlotte A L	Octahydropyrrolo[3,4-C]pyrrole derivatives
EP1767537A1 (en)	2005-09-21	2007-03-28	Cellzome (UK) Ltd.	Pyrimidine compounds for the treatment of inflammatory disorders
WO2007090853A1 (en)	2006-02-10	2007-08-16	Cellzome (Uk) Ltd.	Enantiomers of amino pyrimidine compounds for the treatment of inflammatory disorders
WO2007090854A1 (en)	2006-02-10	2007-08-16	Cellzome (Uk) Ltd.	Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders
EP1829879A1 (en)	2006-02-10	2007-09-05	Cellzome (UK) Ltd.	Amino pyrimidine compounds for the treatment of inflammatory disorders
WO2008074445A1 (en)	2006-12-18	2008-06-26	Ucb Pharma, S.A.	Novel tricyclic and heterotricyclic derivatives, processes for preparing them, pharmaceutical compositions thereof
PE20091035A1 (es)	2007-11-30	2009-07-16	Palau Pharma Sa	Derivados de 2-aminopirimidina

2007
- 2007-07-10 PE PE2007000888A patent/PE20080520A1/es not_active Application Discontinuation
- 2007-07-10 EP EP07796782.6A patent/EP2040549B1/en active Active
- 2007-07-10 ES ES07796782.6T patent/ES2441958T3/es active Active
- 2007-07-10 TW TW096124984A patent/TW200821315A/zh unknown
- 2007-07-10 BR BRPI0715452-6A patent/BRPI0715452A2/pt not_active IP Right Cessation
- 2007-07-10 KR KR1020097002520A patent/KR20090028819A/ko not_active Withdrawn
- 2007-07-10 CN CNA2007800333205A patent/CN101511190A/zh active Pending
- 2007-07-10 JP JP2009519500A patent/JP5352458B2/ja not_active Expired - Fee Related
- 2007-07-10 US US11/827,354 patent/US7576092B2/en active Active
- 2007-07-10 EA EA200970113A patent/EA015344B1/ru not_active IP Right Cessation
- 2007-07-10 WO PCT/US2007/015763 patent/WO2008008359A2/en not_active Ceased
- 2007-07-10 CA CA002657908A patent/CA2657908A1/en not_active Abandoned
- 2007-07-10 CL CL200702007A patent/CL2007002007A1/es unknown
- 2007-07-10 MY MYPI20090109A patent/MY145349A/en unknown
- 2007-07-10 MX MX2009000457A patent/MX2009000457A/es unknown
- 2007-07-10 AU AU2007272956A patent/AU2007272956B2/en not_active Ceased
- 2007-07-11 UY UY30479A patent/UY30479A1/es unknown
- 2007-07-11 AR ARP070103087A patent/AR061891A1/es not_active Application Discontinuation
2009
- 2009-01-11 IL IL196448A patent/IL196448A0/en unknown
- 2009-01-12 EC EC2009009061A patent/ECSP099061A/es unknown
- 2009-01-16 NO NO20090268A patent/NO20090268L/no not_active Application Discontinuation
- 2009-01-22 CO CO09005353A patent/CO6150182A2/es unknown
- 2009-02-10 ZA ZA200900959A patent/ZA200900959B/xx unknown
- 2009-02-11 CR CR10609A patent/CR10609A/es not_active Application Discontinuation
- 2009-07-02 US US12/496,932 patent/US8030321B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20090325927A1 (en)	2009-12-31
EP2040549A2 (en)	2009-04-01
BRPI0715452A2 (pt)	2013-03-05
AR061891A1 (es)	2008-10-01
MX2009000457A (es)	2009-01-27
KR20090028819A (ko)	2009-03-19
AU2007272956B2 (en)	2013-05-02
NO20090268L (no)	2009-03-06
PE20080520A1 (es)	2008-06-13
EA015344B1 (ru)	2011-06-30
JP2009543775A (ja)	2009-12-10
CO6150182A2 (es)	2010-04-20
CN101511190A (zh)	2009-08-19
UY30479A1 (es)	2008-01-31
EP2040549B1 (en)	2013-10-23
TW200821315A (en)	2008-05-16
US7576092B2 (en)	2009-08-18
WO2008008359A2 (en)	2008-01-17
EP2040549A4 (en)	2010-09-08
US8030321B2 (en)	2011-10-04
IL196448A0 (en)	2009-11-18
AU2007272956A1 (en)	2008-01-17
CR10609A (es)	2009-06-04
ZA200900959B (en)	2010-04-28
ES2441958T3 (es)	2014-02-07
JP5352458B2 (ja)	2013-11-27
MY145349A (en)	2012-01-31
EA200970113A1 (ru)	2009-06-30
WO2008008359A3 (en)	2008-12-31
US20080015200A1 (en)	2008-01-17
ECSP099061A (es)	2009-02-27
CA2657908A1 (en)	2008-01-17

Publication	Publication Date	Title
ECSP12011965A (es)	2012-07-31	Anticuerpos neutralizadores contra el receptor de prolactina y su uso terapéutico
CL2008000467A1 (es)	2008-08-22	Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma
BRPI0911563A2 (pt)	2016-07-12	uso de antagonista da progesterona
BRPI0921433A2 (pt)	2017-06-06	uso de anticorpos anti-cs1 para o tratamento de linfomas raros
CY2017021I2 (el)	2025-05-09	Υψηλης συναφειας ανθρωπινα αντισωματα προς pcsk9
BRPI0814768A2 (pt)	2015-03-03	Uso terapêutico de anticorpos de receptores anti-tweak
BRPI0907628A2 (pt)	2015-07-21	Derivados bicíclicos de carboxamidas azabicíclicas, preparação dos mesmos e uso terapêutico dos mesmos
CL2013000930A1 (es)	2014-03-28	Anticuerpo para interleuquina 17 (il-17); uso de dicho anticuerpo para tratar soriasis usando antagonistas de il-17.
FR2945534B1 (fr)	2012-11-16	DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
BR112012003792A2 (pt)	2016-04-19	gel tópico, e, uso do gel tópico.
BR112012002331A2 (pt)	2019-09-24	composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BR112013009465A2 (pt)	2016-07-12	compósitos reforçados com fibra, pré-forma axissimétrica continua para uso nos mesmos e respectivos métodos de produção
BRPI0921802A8 (pt)	2018-03-13	uso de um inibidor de fosfatidilinositol-3-cinase (pi3k) e um inibidor de mtor,bem como composição e combinação farmacêuticas os compreendendo.
PT2590976E (pt)	2016-01-20	Derivados da imidazopiridina, seu processo de preparação e sua utilização terapêutica
BRPI1015006A2 (pt)	2019-09-24	uso tópico, periocular, ou intraocular de tocotrienóis para o tratamento de doenças oftálmicas
BR112013005071A2 (pt)	2016-04-26	ligante de cimento, concreto e uso de ligante de cimento
PL1904056T3 (pl)	2009-09-30	Zastosowanie makrolidu do przywracania czucia rogówkowego
FR2953520B1 (fr)	2011-11-25	Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique
BRPI0813456A2 (pt)	2014-12-23	Composto, uso do mesmo, composição farmacêutica, e, métodos para tratar um mamífero sofrendo de um distúrbio e de uma doença
BRPI0913188A2 (pt)	2016-01-12	moduladores de receptores 5-ht3, métodos de fabricação, e uso dos mesmos
CO6852025A2 (es)	2014-01-30	El anticuerpo neutralizador del receptor de prolactina mat3 y su uso terapéutico
BRPI0920222A2 (pt)	2019-09-24	composições catalisadoras e métodos de produção e uso das mesmas
BRPI0923896A2 (pt)	2015-07-28	Rede de fibra dual e métodos de sua produção e uso
BR112013025392A2 (pt)	2017-10-24	composição, uso de perlita e de pelo menos um polímero vinílico e processo de tratamento cosmético
FR2952934B1 (fr)	2012-06-22	Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique